Evidence map›Paper›PMID 36159701›Full record

ArticleFrontiers in bioengineering and biotechnology2022

Effects of taxifolin from enzymatic hydrolysis of

Sun-Min Park, Yi-Chang He, Chun Gong, Wei Gao, Young-Soo Bae, Chuanling Si, Kwang-Hyun Park, Sun-Eun Choi

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Inhibitory Effects ofJournal of microbiology and biotechnology · 2026
    Article
  2. Article
  3. In Vitro Study on the Effects ofInternational journal of molecular sciences · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Life (Basel, Switzerland) · 2024
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sun-Min ParkDepartment of Forest Biomaterials Engineering, College of Forest and Environmental Sciences, Kangwon National University, Kangwon, South Korea.
Yi-Chang HeKey Lab of Agricultural Resources and Ecology of Poyang Lake Basin, College of Land Resources and Environment, Jiangxi Agricultural University, Nanchang, Jiangxi, China.
Chun GongJiangxi Academy of Forestry, Nanchang, Jiangxi, China.
Wei GaoJiangxi Academy of Forestry, Nanchang, Jiangxi, China.
Young-Soo BaeDepartment of Forest Biomaterials Engineering, College of Forest and Environmental Sciences, Kangwon National University, Kangwon, South Korea.
Chuanling SiTianjin Key Laboratory of Pulp and Paper, Tianjin University of Science and Technology, Tianjin, China.
Kwang-Hyun ParkDepartment of Emergency Medicine and BioMedical Science Graduate Program (BMSGP), Chonnam National University, Hwasun, South Korea.
Sun-Eun ChoiDepartment of Forest Biomaterials Engineering, College of Forest and Environmental Sciences, Kangwon National University, Kangwon, South Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Flavonoid aglycones possess biological activities, such as antioxidant and antidiabetic activities compared to glycosides. Taxifolin, a flavonoid aglycones, is detected only in trace amounts in nature and is not easily observed. Therefore, in this study, to investigate the hair tonic and hair loss inhibitors effect of taxifolin, high content of taxifolin aglycone extract was prepared by enzymatic hydrolysis. Taxifolin effectively regulates the apoptosis of dermal papilla cells, which is associated with hair loss, based on its strong antioxidant activities. However, inhibition of dihydrotestosterone (DHT), which is a major cause of male pattern hair loss, was significantly reduced with taxifolin treatment compared with minoxidil, as a positive control. It was also confirmed that a representative factor for promoting hair growth, IGF-1, was significantly increased, and that TGF-β1, a representative biomarker for hair loss, was significantly reduced with taxifolin treatment. These results suggest that taxifolin from enzymatic hydrolysis of RM is a potential treatment for hair loss and a hair growth enhancer.

Indexed as

dihydrotestosteroneenzyme hydrolysishuman follicle dermal papilla cellsRhododendron mucrotulatumtaxifolin

Identifiers

PMID36159701
PMCPMC9492874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.